Company Overview

Ajuo esn jeu For per Results IHL-42X was well tolerated. No serious treatment emergent adverse events (TEAE) were reported during the study. - Low dose IHL-42X had the lowest proportion of participants reporting TEAES and the fewest number of total TEAES compared to other treatment groups including placebo. Incannex One participant on high dose IHL-42X had a TEAE that caused them to be withdrawn from the study. However, they tested positive for illicit substances other than cannabis. - One participant on placebo had a severe TEAE that was not linked to the study drug. Proportion of participants reporting (%) Total number reported 90 80 70 60 50 40 30 20 10 0 25 20 15 10 5 0 Lu Low Placebo ■Total TEAE Placebo Low ■Total TEAE Medium Related TEAE Lead Assets ooooooooo Medium Related TEAE High High Investor Presentation 17

View entire presentation